Ambulatory Cardiac Monitoring Devices Market

Ambulatory Cardiac Monitoring Devices Market (Type: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Heart Patients Demanding Advanced Cardiac Monitoring Devices

Ambulatory cardiac monitors are small, movable electrocardiograph machines that can record the heart’s rhythm. The features in such monitors vary based on the length of recording time and the ability to send the recordings over the phone. Most professional experts use ambulatory cardiac monitors to assess heartbeat rate over time, correlate symptoms with the heartbeat, diagnose abnormal heart rhythms, and analyze other symptoms a heart can have. These devices help monitor the heart with increased detection time and with more precise results as compared to conventional heart monitors. This is likely to boost the global ambulatory cardiac monitoring devices market during the forecast period.

In simpler terms, ambulatory cardiac monitoring devices are used to assist doctors to diagnose irregular cardiac arrhythmias that occur only sporadically and unpredictably. Such arrhythmias often exhibit sudden symptoms, but usually are not present by the time the patient gets to a doctor. For this reason, many symptom-producing cardiac arrhythmias are challenging or unlikely to diagnose with conventional ECGs. Ambulatory cardiac monitoring devices have proven useful to monitor and record the heartbeats for longer spans to capture a brief, irregular, but potentially vital arrhythmia. The growing number of heart-related cases across the world owing to factors such as increasing obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles, are expected to be major factors driving the global ambulatory cardiac monitoring devices market.

ambulatory cardiac monitoring devices market infographic

Request a sample to get extensive insights into the Ambulatory Cardiac Monitoring Devices Market

Cardiac Patients at Greater Risks amid COVID-19 Crisis

COVID-19 has posed various kinds of challenges for doctors whose cardiac patients are at-risk and hesitant to schedule a visit. People with cardiac issues are concerned about coronavirus, but in their caution, they can die from an unmonitored, untreated cardiac condition. Besides, the number of deaths from cardiac diseases is more than that of COVID-19 patients. However, at a time when cardiac monitoring is more critically important than ever, patients may have greater hesitation to visit a hospital. Moreover, people in rural areas face more challenges of having to travel to the doctor, as they might not have at least one cardiologist nearby. Interns and practitioners are being trained to use cardiac monitoring devices in case of emergencies. This has propelled the ambulatory cardiac monitoring devices market. However, stringent regulations for travel, manufacturing, supply chain, and trade to limit the virus have impacted the production and distribution of such devices.

There has been a notable decrease in admissions for cardiac arrests and failure, owing to the threat coronavirus poses on heart patients. Moreover, there is accumulating evidence to suggest COVD-19 has vital and even long-term cardiac effects, which may lead to a series of heart failure patients leading to a new crisis. Thus, the demand for the use of ambulatory cardiac monitoring devices is hindered during this time. However, with the growing number of vaccinations in various nations and innovation in medicines and drugs, the global ambulatory cardiac monitoring devices market is expected to surge post-COVID-19.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Growing Need for Innovative Technology in Heart-related Issues Fuel Global Market

The most advanced and minimally invasive surgery utilization to improve patients' heart activity and intensify the outcomes of various cardiac procedures is one of the key factors propelling the growth of the ambulatory cardiac monitoring devices market. Moreover, the rising demand for advanced cardiac devices, such as Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry helping the future ambulatory cardiac monitoring devices market growth. Furthermore, rising government and people investment in healthcare and favorable reimbursement policies are among the major factors expanding the ambulatory cardiac monitoring devices market.

ambulatory cardiac monitoring devices market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Ambulatory Cardiac Monitoring Devices Market

Analysts’ Viewpoint

The global medical data suggests that one out of 10 people suffers from heart-related issues, including coronary heart disease, angina, high and low blood pressure, heart attack, arrhythmia, and valve blockage. Thus, ambulatory cardiac monitoring devices have become necessary to track and monitor the heart to avoid fatal outcomes of such diseases. Cardiac monitoring is also crucial in the administration of heart attacks, the value of cardiac output, and for monitoring of sepsis cases. Ambulatory cardiac monitoring devices are also used to detect, eliminate, and restrict mycoplasma infection in cell culture, making them fit for use in research institutions and organizations. The growing concerns of heart patients and an increasing number of such patients are driving the ambulatory cardiac monitoring devices market.

Ambulatory Cardiac Monitoring Devices Market: Overview

  • The global ambulatory cardiac monitoring devices market was valued at US$ 13.5 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Rise in demand for prolonged ECG monitoring & self-care management and increase in burden of cardiovascular diseases drive the need of ambulatory cardiac monitoring devices. Key industry developments, including partnerships, mergers & acquisitions, and collaborations, are anticipated to fuel the growth of the global ambulatory cardiac monitoring devices market.
  • Obesity, diabetes mellitus, smoking, high cholesterol, high blood pressure, and sedentary lifestyles are the leading causes of heart failure. Rise in number of people afflicted by these diseases is expected to increase the demand for ambulatory cardiac monitoring devices.
  • According to the American Heart Association’s 2017 Heart Diseases and Stroke Statistics update, the number of people diagnosed with heart failure is increasing and projected to rise by 46% by 2030, resulting in over 8 million people with heart failure. Around 22 million people are living with congestive heart failure globally, with 2 million people diagnosed every year. According to the American Heart Association, congestive heart failure is one of the leading causes of death in the U.S., accounting for 8.5% of the deaths.
  • According to the World Journal of Cardiovascular Diseases, over 7 million deaths occur due to sudden cardiac arrest globally every year. Sudden cardiac arrest accounts for about 20% of all mortalities in the West.
  • Utilization of implantable cardiac monitors has increased to keep track of irregularity of the heart rhythm compared to Holter and other external patch. Insertable cardiac monitors (ICMs, or implantable loop recorders, ILRs) are small subcutaneous devices that continuously monitor the heart rhythm and record events for several years.
  • Insertable cardiac monitors are commonly used to monitor patients with syncope or stroke of unknown origin for infrequent rhythm abnormalities, as well as for long-term monitoring of atrial fibrillation post ablation. ICMs i.e., insertable cardiac monitors, are small, subcutaneously implanted devices offering continuous ambulatory electrocardiogram (ECG) monitoring with a lifespan of up to three years.

Ambulatory Cardiac Monitoring Devices Market: Segmentation

  • The global ambulatory cardiac monitoring devices market has been segmented based on type and region
  • In terms of type, the global ambulatory cardiac monitoring devices market has been classified into ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. ECG devices have been bifurcated into resting ECG devices and stress ECG devices.
  • The ECG devices segment captured the largest market share in 2020 and the trend is likely to continue during the forecast period. Government support is a major factor driving the ECG devices segment in Singapore. Export and usage of medical equipment are rising due to expansion of the domestic market and foreign investments.

Ambulatory Cardiac Monitoring Devices Market: Regional Segmentation

  • In terms of region, the global ambulatory cardiac monitoring devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to be a highly attractive market from 2021 to 2031. Significant revenue from the region can be attributed to increase in government and private funding and large volume of tests for cardiac diseases performed. Moreover, high prevalence of heart failure due to aging population and changes in dietary habits is anticipated to drive the ambulatory cardiac monitoring devices market in North America.
  • The ambulatory cardiac monitoring devices market in Asia Pacific is expected to be driven by high adoption of ambulatory cardiac monitoring devices. According to a study published in the Radcliffe Cardiology journal, heart failure is a major health problem in Asia Pacific and its prevalence seems to be higher than countries in the West. Rise in awareness about heart failure and risk of sudden cardiac arrest associated with this condition propels the market in the region.

Ambulatory Cardiac Monitoring Devices Market: Major Players

  • Key players operating in the global ambulatory cardiac monitoring devices market are
    • Abbott
    • Boston Scientific Corporation
    • GE Healthcare
    • Hill-Rom Holdings
    • Koninklijke Philips N.V.
    • Medtronic
    • Nihon Kohden Corporation
    • Asahi Kasei Medical Co., Ltd.
  • These players focus on adopting various strategies to expand product offerings and to strengthen geographic presence across the globe. Technological advancements, mergers & acquisition, expansion of product portfolio, and rise in research & development are strategies adopted by companies to expand market presence.

Ambulatory Cardiac Monitoring Devices Market – Segmentation

Type
  • ECG Devices
    • Resting ECG Devices
    • Stress ECG Devices
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of ambulatory cardiac monitoring devices market?

Ambulatory cardiac monitoring devices market to cross valuation of US$29 Bn by 2031

What are the key driving factors for the growth of the ambulatory cardiac monitoring devices market?

Ambulatory cardiac monitoring devices market is driven by rise in demand for prolonged ECG monitoring & self-care management and increase in burden of cardiovascular diseases

Which region is expected to project the highest market share in the global ambulatory cardiac monitoring devices market?

North America accounted for a major share of the global ambulatory cardiac monitoring devices market

Which is the rising prominent segment in the ambulatory cardiac monitoring devices market?

The ECG devices segment captured the largest market share in 2020 and the trend is likely to continue during the forecast period

Who are the key players in the global ambulatory cardiac monitoring devices market?

Key players operating in the global ambulatory cardiac monitoring devices market are Abbott, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, Asahi Kasei Medical Co., Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Ambulatory Cardiac Monitoring Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Prevalence of Heart Failure

        5.2. Brand Analysis

        5.3. Patient Pathway for Ambulatory Cardiac Monitoring

        5.4. Value Chain Analysis

        5.5. Pricing Analysis

        5.6. Reimbursement Scenario

        5.7. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Type, 2017–2031

            6.3.1. ECG Devices

                6.3.1.1. Resting ECG Devices

                6.3.1.2. Stress ECG Devices

            6.3.2. Holter Monitors

            6.3.3. Event Monitors

            6.3.4. Implantable Loop Recorders

            6.3.5. Mobile Cardiac Telemetry

        6.4. Market Attractiveness Analysis, by Type 

    7. Global Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast, by Region

        7.1. Key Findings

        7.2. Market Value Forecast, by Region

            7.2.1. North America 

            7.2.2. Europe 

            7.2.3. Asia Pacific 

            7.2.4. Latin America 

            7.2.5. Middle East & Africa 

        7.3. Market Attractiveness Analysis, by Country/Region

    8. North America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

        8.1. Introduction

            8.1.1. Key Findings

        8.2. Market Value Forecast, by Type, 2017–2031

            8.2.1. ECG Devices

                8.2.1.1. Resting ECG Devices

                8.2.1.2. Stress ECG Devices

            8.2.2. Holter Monitors

            8.2.3. Event Monitors

            8.2.4. Implantable Loop Recorders

            8.2.5. Mobile Cardiac Telemetry

        8.3. Market Value Forecast, by Country, 2017–2031

            8.3.1. U.S.

            8.3.2. Canada

        8.4. Market Attractiveness Analysis 

            8.4.1. By Type 

            8.4.2. By Country

    9. Europe Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Type, 2017–2031

            9.2.1. ECG Devices

                9.2.1.1. Resting ECG Devices

                9.2.1.2. Stress ECG Devices

            9.2.2. Holter Monitors

            9.2.3. Event Monitors

            9.2.4. Implantable Loop Recorders

            9.2.5. Mobile Cardiac Telemetry

        9.3. Market Value Forecast, by Country/Sub-region, 2017–2031

            9.3.1. Germany

            9.3.2. U.K.

            9.3.3. France

            9.3.4. Spain

            9.3.5. Italy

            9.3.6. Rest of Europe

        9.4. Market Attractiveness Analysis 

            9.4.1. By Type 

            9.4.2. By Country/Sub-region

    10. Asia Pacific Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Type, 2017–2031

            10.2.1. ECG Devices

                10.2.1.1. Resting ECG Devices

                10.2.1.2. Stress ECG Devices

            10.2.2. Holter Monitors

            10.2.3. Event Monitors

            10.2.4. Implantable Loop Recorders

            10.2.5. Mobile Cardiac Telemetry

        10.3. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.3.1. China

            10.3.2. Japan

            10.3.3. India

            10.3.4. Australia & New Zealand

            10.3.5. Rest of Asia Pacific

        10.4. Market Attractiveness Analysis 

            10.4.1. By Type 

            10.4.2. By Country/Sub-region

    11. Latin America Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017–2031

            11.2.1. ECG Devices

                11.2.1.1. Resting ECG Devices

                11.2.1.2. Stress ECG Devices

            11.2.2. Holter Monitors

            11.2.3. Event Monitors

            11.2.4. Implantable Loop Recorders

            11.2.5. Mobile Cardiac Telemetry

        11.3. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.3.1. Brazil

            11.3.2. Mexico

            11.3.3. Rest of Latin America

        11.4. Market Attractiveness Analysis 

            11.4.1. By Type 

            11.4.2. By Country/Sub-region

    12. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017–2031

            12.2.1. ECG Devices

                12.2.1.1. Resting ECG Devices

                12.2.1.2. Stress ECG Devices

            12.2.2. Holter Monitors

            12.2.3. Event Monitors

            12.2.4. Implantable Loop Recorders

            12.2.5. Mobile Cardiac Telemetry

        12.3. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.3.1. GCC Countries

            12.3.2. South Africa

            12.3.3. Rest of Middle East & Africa

        12.4. Market Attractiveness Analysis 

            12.4.1. By Type 

            12.4.2. By Country/Sub-region

    13. Competition Landscape

        13.1. Market Share Analysis, by Company, 2020

        13.2. Company Profiles

            13.2.1. Abbott

                13.2.1.1. Company Overview

                13.2.1.2. Company Financials

                13.2.1.3. Growth Strategies

                13.2.1.4. SWOT Analysis

            13.2.2. Boston Scientific Corporation

                13.2.2.1. Company Overview

                13.2.2.2. Company Financials

                13.2.2.3. Growth Strategies

                13.2.2.4. SWOT Analysis

            13.2.3. GE Healthcare

                13.2.3.1. Company Overview

                13.2.3.2. Company Financials

                13.2.3.3. Growth Strategies

                13.2.3.4. SWOT Analysis

            13.2.4. Hill-Rom Holdings

                13.2.4.1. Company Overview

                13.2.4.2. Company Financials

                13.2.4.3. Growth Strategies

                13.2.4.4. SWOT Analysis

            13.2.5. Koninklijke Philips N.V.

                13.2.5.1. Company Overview

                13.2.5.2. Company Financials

                13.2.5.3. Growth Strategies

                13.2.5.4. SWOT Analysis

            13.2.6. Medtronic

                13.2.6.1. Company Overview

                13.2.6.2. Company Financials

                13.2.6.3. Growth Strategies

                13.2.6.4. SWOT Analysis

            13.2.7. Nihon Kohden Corporation

                13.2.7.1. Company Overview

                13.2.7.2. Company Financials

                13.2.7.3. Growth Strategies

                13.2.7.4. SWOT Analysis

            13.2.8. Asahi Kasei Medical Co., Ltd.

                13.2.8.1. Company Overview

                13.2.8.2. Company Financials

                13.2.8.3. Growth Strategies

                13.2.8.4. SWOT Analysis

    List of Tables

    Table 01: Global Stroke Incident Cases

    Table 02: Global Prevalence of Heart Failure (2017)

    Table 03: Status of Cardiac Surgeries in Countries in South Asia 2016–2017

    Table 04: Status of Cardiac Surgeries in North America 

    Table 05: New Zealand all cardiac surgery patients in 2016: age and gender

    Table 06: Europe Hospital discharge rates for in-patients with diseases of the cardiovascular system, 2016-2017

    Table 07: Key Product/Brand Analysis of Implantable Loop Recorder

    Table 08: Key Product/Brand Analysis of Holter Monitors

    Table 09: Key Product/Brand Analysis of ECG

    Table 10: Key Product/Brand Analysis of Event Monitors

    Table 11: Key Product/Brand Analysis of Event Monitors

    Table 12: Key Product/Brand Analysis of Mobile Cardiac Telemetry

    Table 13: Ambulatory Cardiac Monitoring Devices Procedures performed till 2018

    Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019

    Table 15: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 16: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 17: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 18: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 19: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 20: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 21: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 23: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 24: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 25: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 26: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 27: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 28: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 29: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 30: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 31: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 32: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 33: GE Healthcare Business Overview

    Table 34: Koninklijke Philips N.V. Business Overview

    Table 35: Medtronic plc Business Overview

    Table 36: Abbott Laboratories Business Overview

    Table 37: Boston Scientific Corporation Business Overview

    Table 38: Hill-Rom Holdings, Inc. Business Overview

    Table 39: Nihon Kohden Corporation Business Overview

    Table 40: Asahi Kasei Medical Co., Ltd. Business Overview

    List of Figures

    Figure 01: Global Ambulatory Cardiac Monitoring Devices Market Share, by Type

    Figure 02: Global Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 03: Procedures performed in 2017 (New Zealand)

    Figure 04: Procedures performed in 2017 (Australia)

    Figure 05: Value Chain Analysis

    Figure 06: Global Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 07: Global Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 08: Global Ambulatory Cardiac Monitoring Devices Market Analysis, by Region

    Figure 09: Global Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Region, 2020 and 2031

    Figure 10: Global Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Region, 2021–2031

    Figure 11: North America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 12: North America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country, 2020 and 2031

    Figure 13: North America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country, 2021–2031

    Figure 14: North America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 15: North America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 16: Europe Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 17: Europe Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 18: Europe Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 19: Europe Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 20: Europe Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 21: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 22: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 23: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 24: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 25: Asia Pacific Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 26: Latin America Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 27: Latin America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 28: Latin America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 29: Latin America Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 30: Latin America Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 31: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 32: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 33: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 34: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 35: Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 36: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 37: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 38: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 39: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 40: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 41: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 42: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 43: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 44: Medtronic plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 45: Medtronic plc Breakdown of Net Sales (%), by Region/Country, 2020

    Figure 46: Medtronic plc Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 47: Medtronic plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 48: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 49: Abbott Laboratories Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 50: Abbott Laboratories Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 51: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 52: Boston Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 53: Boston Scientific Corporation Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 54: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 55: Boston Scientific Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 56: Hill-Rom Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 57: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2020

    Figure 58: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 59: Hill-Rom Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 60: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 61: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 62: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 63: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 64: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 65: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 66: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 67: Asahi Kasei Medical Co., Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Copyright © Transparency Market Research, Inc. All Rights reserved